Table 4 Univariate and multivariate analyses of progression-free survival using a Cox proportional hazards model in patients with cervical adenocarcinoma.
Factor | Patients | Univariate analysis | Multivariate analysis | ||||
---|---|---|---|---|---|---|---|
n = 82 | HR | 95% CI | p value | HR | 95% CI | p value | |
Age (years) | |||||||
< 60 | 58 | 0.552 | 0.236–1.293 | 0.171 | |||
≥ 60 | 24 | ref | |||||
FIGO stage | |||||||
< IIB | 58 | 0.194 | 0.081–0.464 | < 0.0001 | 0.85 | 0.252–2.867 | 0.793 |
≥ IIB | 24 | ref | ref | ||||
Histology | |||||||
Non-gastric type | 69 | 0.819 | 0.277–2.422 | 0.819 | |||
Gastric type | 13 | ref | |||||
Tumor size (mm) | |||||||
< 40 | 50 | 0.135 | 0.050–0.369 | 0.0001 | 0.161 | 0.036–0.719 | 0.017 |
≥ 40 | 32 | ref | ref | ||||
Metastasis Pelvic Lymph node | |||||||
Negative | 65 | 0.379 | 0.162–0.889 | 0.026 | 0.553 | 0.165–1.858 | 0.338 |
Positive | 17 | ref | ref | ||||
Metastasis Paraaortic Lymph node | |||||||
Negative | 79 | 0.209 | 0.061–0.707 | 0.012 | ref | ||
Positive | 3 | ref | 1.828 | 0.292–11.466 | 0.519 | ||
Metastasis distance | |||||||
Negative | 81 | 0.078 | 0.009–0.644 | 0.018 | 0.503 | 0.047–5.320 | 0.568 |
Positive | 1 | ref | ref | ||||
Metastasis LSVI | |||||||
No | 29 | 0.453 | 0.087–2.353 | 0.004 | 0.065 | 0.007–0.597 | 0.016 |
Yes | 39 | ref | ref | ||||
p16INK4A expression | |||||||
Negative | 22 | ref | ref | ||||
Positive | 60 | 0.376 | 0.162–0.873 | 0.023 | 0.965 | 0.331–2.812 | 0.948 |